<http://webisa.webdatacommons.org/90258569>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<nrc.gov> .
<http://webisa.webdatacommons.org/prov/479123385>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/90258569> .
<http://webisa.webdatacommons.org/90258569>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/483348920>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/90258569> .
<http://webisa.webdatacommons.org/90258569>	<http://www.w3.org/ns/prov#value>	"In addition, the licensee or other entity shall require the laboratory to retest all specimens that analyzed as positive for that drug or metabolite, or as adulterated, substituted, dilute, or" .